By introducing the direct cellular transport optimization properties of the GHR peptide variant TB-500, researchers are able to track how the regulation of globular actin (G-actin) into filamentous actin (F-actin) accelerates cellular motility, allowing defensive and structural cells to rapidly populate a wound matrix
Mari RM, Le Biez E, Busson P, Schaeffer S, Boiteau L, Dupuy B, Viader F
Multi-compound blends require more attention than single-ingredient products
PubMed Central PMCID: PMC3829298
Where It Goes The injection is subcutaneous, given in the abdomen (avoiding a 2-inch radius around the belly button), upper outer thigh, or back of the upper arm